Search By:
Products
Injury
Topic
Company
Industry
Bayer may have misrepresented the effectiveness of its "One-A-Day WeightSmart" dietary supplement.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topics
- Defective Product or Service
- Misrepresentation
Product or Service
- Vitamins, Nutritional Supplements and Over The Counter Medicines
Injury Type
- Monetary Loss
Investigation Details
Investigation and pending class action lawsuit against Bayer Corporation and Bayer HealthCare.
Bayer has promoted, advertised and marketed its "One-A-Day WeightSmart" dietary supplement products as "a safe way to supplement the effort you are making to better control your weight." Trusting consumers purchased these products hoping that the promises made were true. These promises included promises that One-A-Day WeightSmart had the ability to increase metabolism, prevent weight gain associated with the decline in metabolism that occurs after the age of 30, and help to generally promote weight maintenance.
In reality, Bayer's One-A-Day WeightSmart products do not live up to these promises, a fact which was confirmed by the January 2007 Consent Decree entered into between Bayer and the Federal Trade Commission, in which Bayer agreed to pay a multi-million dollar civil penalty for violating an earlier Federal Trade Commission order governing their promotion, advertising and marketing of its "One-A-Day" products.
Bayer has promoted, advertised and marketed its "One-A-Day WeightSmart" dietary supplement products as "a safe way to supplement the effort you are making to better control your weight." Trusting consumers purchased these products hoping that the promises made were true. These promises included promises that One-A-Day WeightSmart had the ability to increase metabolism, prevent weight gain associated with the decline in metabolism that occurs after the age of 30, and help to generally promote weight maintenance.
In reality, Bayer's One-A-Day WeightSmart products do not live up to these promises, a fact which was confirmed by the January 2007 Consent Decree entered into between Bayer and the Federal Trade Commission, in which Bayer agreed to pay a multi-million dollar civil penalty for violating an earlier Federal Trade Commission order governing their promotion, advertising and marketing of its "One-A-Day" products.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| Bayer AG | Bayer AG manufactures pharmaceuticals and consumer products. |